Ozempic

Health

Ozempic Blindness Warning: FDA Orders Eye Risk Labels on GLP-1 Drugs

The United States Food and Drug Administration has ordered makers of Ozempic, Wegovy, Mounjaro and Zepbound to warn patients that the weight-loss and diabetes drugs carry a rare risk of a serious eye condition that can cause permanent vision loss. The agency announced the class-wide labelling change on Monday 9 November 2026, and it applies to every GLP-1 drug sold…